Tesfay MZ, Cios A, Cheng Z, Ferdous KU, Shelton RS, Mustafa B, Elliott NM, Raupach EA, Simoes CC, Miousse IR, Urbaniak A, Bauer MA, Siegel ER, Post SR, Chamcheu JC, Govindarajan R, Grdzelishvili VZ, Cannon MJ, Fernandez-Zapico ME, Basnakian AG, Chabu CY, Moaven O, Borad MJ, Nagalo BM. Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response. Journal for ImmunoTherapy of Cancer. 2026;14(5)
